Interestingly, PIP4K2C expression has been associated with outcomes in Acute Myeloid Leukemia (AML) (Lima et al., 2019), while CSNK2A2 has been associated significantly with prognoses of 14 different cancer types (Strum, Gyenis & Litchfield, 2022). This evidence concerns the gene PIP4K2C and acute myeloid leukemia.